Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$331,724,370
-$71,684,535 QoQ
Shares Held
13,775,929
-4.1% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#49
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $7,122,175,515 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,895,765 | $2,273,837,603 | |
| 2 | JNJ |
Johnson & Johnson
|
5,660,854 | $1,437,687,090 | |
| 3 | ABBV |
AbbVie Inc.
|
3,945,546 | $992,857,195 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,169,107 | $792,730,249 | |
| 5 | AMGN |
Amgen Inc
|
1,520,877 | $550,739,979 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,962,648 | $374,300,948 | |
| 7 | PFE |
Pfizer Inc
This page
|
13,775,929 | $331,724,370 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,092,121 | $293,408,012 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $331,724,370 | 13,775,929 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $403,408,905 | 14,366,414 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $376,773,129 | 15,131,451 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $397,868,110 | 15,614,918 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $378,171,051 | 15,601,116 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $332,819,284 | 13,134,147 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $373,426,649 | 14,075,637 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $379,657,030 | 13,118,764 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $351,830,201 | 12,574,346 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $432,821,550 | 15,597,173 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $452,203,119 | 15,706,951 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $517,172,012 | 15,591,559 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $578,701,680 | 15,777,036 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $705,223,920 | 17,284,900 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $929,172,478 | 18,133,733 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $801,089,726 | 18,306,438 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $965,783,826 | 18,420,443 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $917,094,108 | 17,714,779 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $1,052,835,163 | 17,829,554 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $777,945,998 | 18,087,561 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $707,902,329 | 18,077,179 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $699,930,087 | 19,319,075 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $718,775,581 | 19,526,639 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $817,839,939 | 22,284,489 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $797,316,454 | 24,382,741 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $809,185,238 | 24,791,248 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||